08 February 2021
Jack Shute By Jack Shute

The Impact of Biologics on the Future of Small Molecules.

I've collaborated with multiple leading experts at major small molecule CDMOs to talk about the impact that biologics has has on their industry.

This article featured in the January/February 2021 edition of Speciality Chemicals Magazine. If you'd like to give it a read, got to pages 26 and 27 of the magazine.

Click here to go to the magazine.

If you'd like to talk to me about the article, discuss your hiring plans or chat about advancing your own careers within the CDMO space; please email me at Jack.Shute@lifesci-cm.com.

Share
Back to the top
Jack Shute

Jack Shute is a Director and was a founding member of CM Life Science. In his 7 years with the business he has worked across a range of pharmaceutical markets. Today he manages a team of life science research and pharmaceutical specialists with a global reach.

Recommended.

Building an Impactful Talent Strategy for Your Life Science Start-Up
16 August 2022
Eleanor Doolin Nathan Sharpe By Eleanor Doolin & Nathan Sharpe

Building an Impactful Talent Strategy for Your Life Science Start-Up

Are you attracting the very best industry talent to your start-up? For expert advice on how to thrive in today‚Äôs life science talent market, watch CM Life Science's latest 30-minute webinar. Click to watch.

Pure or Integrated? That is the Question.
26 May 2022
Harriet Wheat By Harriet Wheat

Pure or Integrated? That is the Question.

Developing and manufacturing drugs is more expensive and complicated than ever before. Many outsource to CDMO's, but which approach truly offers the most value? Click to read more.

Is This the Most Exciting Time Ever for CDMOs?
09 December 2021
Harriet Wheat By Harriet Wheat

Is This the Most Exciting Time Ever for CDMOs?

As small-molecule CDMOs pivot their businesses to meet the demands of the life science sector, I spoke with CEO & Founder Tia Lyles-Williams to find out what this really means for the industry. Click to find out more.

How are we Addressing the Lack of Diversity in Clinical Trials?
16 August 2021
Elisabeth Edmonds By Elisabeth Edmonds

How are we Addressing the Lack of Diversity in Clinical Trials?

What are organisations doing to improve diversity in clinical trials? Click to find out what a panel of CRO leaders had to say in our latest live webinar. Now available as a podcast.